Skip Navigation

This Article
Right arrow Full Text (PDF )
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (70)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Crosignani, P.G.
Right arrow Articles by Soliani, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crosignani, P.G.
Right arrow Articles by Soliani, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 6, No. 7, pp. 953-958, 1991
© 1991 European Society of Human Reproduction and Embryology


other

The ESHRE multicentre trial on the treatment of unexplained infertility: a preliminary report*

P.G. Crosignani, D.E. Walters1,2 and A. Soliani

II Department of Obstetrics and Gynaecology, University of Milan Milan, Italy 2Cambridge Research Station, Babraham Hall Cambridge CB2 4AT, UK

Correspondence: 1To whom correspondence should be addressed

Nineteen** European fertility centres participated in a controlled randomized trial aimed at comparing the effectiveness of five methods for the treatment of unexplained infertility. Each centre was invited to employ two of the five treatments being investigated, and the treatment allocated to individual patients was then decided by randomization. The treatments were superovulation alone, and superovulation together with one of the following procedures: intra-uterine insemination (IUI), intra-peritoneal insemination (IPI), gamete intra-Fallopian transfer (GIFT), in-vitro fertilization (IVF). All the patients admitted to the study had experienced >36 months infertility prior to the start of the trial, and only patients <38 years of age were included in the investigation. Further, the study was confined to patients with normal Fallopian tubes, and where there was evidence of spontaneous ovulation. Yet another prerequisite for inclusion in the study was that the male partner was ‘normal’ as regards fertility. Due to unavoidable practical difficulties, the experimental design eventually obtained was severely unbalanced. Nevertheless, objective statistical comparisons were possible among the five treatments, using non-orthogonal analyses of variance. By the completion of the trial 444 patients had been treated in a total of 649 cycles. There was some statistical evidence that the pregnancy rate obtained from superovulation alone was inferior to that obtained by using superovulation together with one of the methods of assisted conception. The pregnancy rate from each method of assisted procreation was found to be vastly better than various estimates of the spontaneous pregnancy rates cited in the literature, and also of the upper limit of the pregnancy rate implied by the pre-treatment period of infertility.

Key words: randomized trials/multicentre/assisted procreation/pregnancy rates

*European Society of Human Reproduction and Embryology. This trial received financial support from ARES-SERONO (Geneva)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
H.K. Snick, J.A. Collins, and J.L.H. Evers
What is the most valid comparison treatment in trials of intrauterine insemination, timed or uninfluenced intercourse? A systematic review and meta-analysis of indirect evidence
Hum. Reprod., October 1, 2008; 23(10): 2239 - 2245.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.M.E. van Rumste, J.E. den Hartog, J.C.M. Dumoulin, J.L.H. Evers, and J.A. Land
Is controlled ovarian stimulation in intrauterine insemination an acceptable therapy in couples with unexplained non-conception in the perspective of multiple pregnancies?
Hum. Reprod., March 1, 2006; 21(3): 701 - 704.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. A. Stewart
Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility: Should the guidelines be changed?
Hum. Reprod., May 1, 2003; 18(5): 903 - 907.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Lahat, A. Raziel, S. Friedler, M. Schieber-Kazir, and R. Ron-El
Long-term follow-up of children born after inadvertent administration of a gonadotrophin-releasing hormone agonist in early pregnancy
Hum. Reprod., October 1, 1999; 14(10): 2656 - 2660.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Nuojua-Huttunen, C. Tomas, R. Bloigu, L. Tuomivaara, and H. Martikainen
Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome
Hum. Reprod., March 1, 1999; 14(3): 698 - 703.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Forti and C. Krausz
Evaluation and Treatment of the Infertile Couple
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4177 - 4188.
[Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.